Department of Integrative Biotechnology, and Biomedical Institute for Convergence at SKKU (BICS), Sungkyunkwan University, Suwon 16419, Korea.
School of Systems Biomedical Science, Soongsil University, Seoul 06978, Korea.
Molecules. 2021 May 20;26(10):3053. doi: 10.3390/molecules26103053.
methanol extract (Ba-ME) is a folk medicine found in the wetlands of Thailand that acts through an anti-inflammatory mechanism that is not understood fully. Here, we examine how the methanol extract of ( can suppress the activator protein 1 (AP-1) signaling pathway and study the activities of Ba-ME in the lipopolysaccharide (LPS)-treated RAW264.7 macrophage cell line and an LPS-induced peritonitis mouse model. Non-toxic concentrations of Ba-ME downregulated the mRNA expression of cytokines, such as cyclooxygenase and chemokine ligand 12, in LPS-stimulated RAW264.7 cells. Transfection experiments with the AP-1-Luc construct, HEK293T cells, and luciferase assays were used to assess whether Ba-ME suppressed the AP-1 functional activation. A Western blot assay confirmed that C-Jun N-terminal kinase is a direct pharmacological target of Ba-ME action. The anti-inflammatory effect of Ba-ME, which functions by β-activated kinase 1 (TAK1) inhibition, was confirmed by using an overexpression strategy and a cellular thermal shift assay. In vivo experiments in a mouse model of LPS-induced peritonitis showed the anti-inflammatory effect of Ba-ME on LPS-stimulated macrophages and acute inflammatory mouse models. We conclude that Ba-ME is a promising anti-inflammatory drug targeting TAK1 in the AP-1 pathway.
甲醇提取物 (Ba-ME) 是一种在泰国湿地发现的民间药物,其作用机制通过抗炎机制尚不完全清楚。在这里,我们研究了 ( 的甲醇提取物如何抑制激活蛋白 1 (AP-1) 信号通路,并研究了 Ba-ME 在脂多糖 (LPS) 处理的 RAW264.7 巨噬细胞系和 LPS 诱导的腹膜炎小鼠模型中的活性。Ba-ME 的无毒浓度下调了 LPS 刺激的 RAW264.7 细胞中细胞因子(如环氧化酶和趋化因子配体 12)的 mRNA 表达。使用 AP-1-Luc 构建体、HEK293T 细胞和荧光素酶测定进行转染实验,以评估 Ba-ME 是否抑制了 AP-1 的功能激活。Western blot 分析证实 c-Jun N 端激酶是 Ba-ME 作用的直接药理靶点。通过过表达策略和细胞热转移测定证实了 Ba-ME 通过 β-激活激酶 1 (TAK1) 抑制的抗炎作用。在 LPS 诱导的腹膜炎小鼠模型中的体内实验表明,Ba-ME 对 LPS 刺激的巨噬细胞和急性炎症小鼠模型具有抗炎作用。我们得出结论,Ba-ME 是一种有前途的针对 AP-1 通路中 TAK1 的抗炎药物。